Controversy: Antenatal steroids

Clinics in Perinatology

Volumn 38, Issue 3, 2011, Pages 529-545

  Wapner, Ronald ^a   Jobe, Alan H ^b  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Corticosteroids; Neurodevelopmental outcomes; Prematurity; Respiratory distress syndrome

Indexed keywords

BETAMETHASONE; BETAMETHASONE ACETATE; BETAMETHASONE ACETATE PLUS BETAMETHASONE SODIUM PHOSPHATE; BETAMETHASONE SODIUM PHOSPHATE; CORTICOSTEROID; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; HYDROCORTISONE; PLACEBO; PROGESTERONE; STEROID; SULFITE;

BINDING AFFINITY; BRAIN HEMORRHAGE; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL PRACTICE; DEACETYLATION; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INDICATION; DRUG INFORMATION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG USE; ENCEPHALOMALACIA; FETUS BLOOD; FETUS LUNG MATURATION; FETUS MATURITY; GROWTH RETARDATION; HEART RATE VARIABILITY; HORMONE DETERMINATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; LUNG VOLUME; NEWBORN SEPSIS; NONHUMAN; OBESITY; PARTICLE SIZE; PREMATURE LABOR; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; TREATMENT DURATION; TWIN PREGNANCY;

FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; UNITED STATES;

EID: 80052285797     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2011.06.013     Document Type: Review

References (89)

1. Crowley P., Chalmers I., Keirse M.J. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990, 97(1):11-25.
2. NIH, Consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995, 273(5):413-418.
3. Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement 2000, 17(2):1-10.
4. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, 3. CD004454.
5. Brownfoot F.C., Crowther C.A., Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2008, 4. CD006764.
6. Crowther C.A., Harding J.E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2007, 3. CD003935.
7. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of RDS in premature infants. Pediatrics 1972, 50(4):515-525.
8. Lipworth B.J. Therapeutic implications of non-genomic glucocorticoid activity. Lancet 2000, 356(9224):87-89.
9. Buttgereit F., Brand M.D., Burmester G.R. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol 1999, 58(2):363-368.
10. Ozdemir H., Guvenal T., Cetin M., et al. A placebo-controlled comparison of effects of repetitive doses of betamethasone and dexamethasone on lung maturation and lung, liver, and body weights of mouse pups. Pediatr Res 2003, 53(1):98-103.
11. Derks J.B., Giussani D.A., Van Dam L.M., et al. Differential effects of betamethasone and dexamethasone fetal administration of parturition in sheep. J Soc Gynecol Investig 1996, 3(6):336-341.
12. Senat M.V., Minoui S., Multon O., et al. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomised study. Br J Obstet Gynaecol 1998, 105(7):749-755.
13. Rotmensch S., Liberati M., Vishne T.H., et al. The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomized trial. Acta Obstet Gynecol Scand 1999, 78(6):493-500.
14. Subtil D., Tiberghien P., Devos P., et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomized trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. Am J Obstet Gynecol 2003, 188(2):524-531.
15. Ballard P.L., Ballard R.A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995, 173(1):254-262.
16. Liggins G.C., Howie R.N. Prevention of respiratory distress syndrome by maternal steroid therapy. Modern perinatal medicine 1974, 415-424. Yearbook Publishers, Chicago. L. Gluck (Ed.).
17. Jobe A.H., Nitsos I., Pillow J.J., et al. Betamethasone dose and formulation for induced lung maturation in fetal sheep. Am J Obstet Gynecol 2009, 201(6). 611,e1-7.
18. Samtani M.N., Lohle M., Grant A., et al. Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use. Drug Metab Dispos 2005, 33(8):1124-1130.
19. Berry L.M., Polk D.H., Ikegami M., et al. Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am J Physiol 1997, 272(6 Pt 2):R1972-R1979.
20. Loehle M., Schwab M., Kadner S., et al. Dose-response effects of betamethasone on maturation of the fetal sheep lung. Am J Obstet Gynecol 2010, 202(2). 186,e1-7.
21. Kutzler M.A., Ruane E.K., Coksaygan T., et al. Effects of three courses of maternally administered dexamethasone at 0.7, 0.75, and 0.8 of gestation on prenatal and postnatal growth in sheep. Pediatrics 2004, 113(2):313-319.
22. Jobe A.H., Newnham J.P., Moss T.J., et al. Differential effects of maternal betamethasone and cortisol on lung maturation and growth in fetal sheep. Am J Obstet Gynecol 2003, 188:22-28.
23. Jobe A.H., Moss T.J., Nitsos I., et al. Betamethasone for lung maturation: testing dose and formulation in fetal sheep. Am J Obstet Gynecol 2007, 97(5):523-526.
24. Jobe A.H., Newnham J., Willet K., et al. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids. Pediatrics 1998, 102:1116-1125.
25. Egerman R.S., Mercer B.M., Doss J.L., et al. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Am J Obstet Gynecol 1998, 179:1120-1123.
26. Elimian A., Garry D., Figueroa R., et al. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial. Obstet Gynecol 2007, 110(1):26-30.
27. Baud O., Foix-L'Helias L., Kaminski M., et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999, 341(16):1190-1196.
28. Lee B.H., Stoll B.J., McDonald S.A., et al. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 2006, 117(5):1503-1510.
29. Feldman D.M., Carbone J., Belden L., et al. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates. Am J Obstet Gynecol 2007, 197(3). 284,e1-4.
30. Onland W., de Laat M.W., Mol B.W., et al. Effects of antenatal corticosteroids given prior to 26 weeks' gestation: a systematic review of randomized controlled trials. Am J Perinatol 2011, 28(1):33-44.
31. Garite T.J., Rumney P.J., Briggs G.G., et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992, 166(2):646-651.
32. Gonzales L.W., Ballard P.L., Ertsey R., et al. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 1986, 62(4):678-691.
33. Bunton T.E., Plopper C.G. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am J Obstet Gynecol 1984, 148(2):203-215.
34. Costeloe K., Hennessy E., Gibson A.T., et al. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000, 106(4):659-671.
35. Hayes E.J., Paul D.A., Stahl G.E., et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol 2008, 111(4):921-926.
36. Mori R., Kusuda S., Fujimura M. Antenatal corticosteroids promote survival of extremely preterm infants born at 22-23 weeks of gestation. J Pediatr 2011, 159(1). 110-4,e1.
37. Davidoff M.J., Dias T., Damus K., et al. Changes in the gestational age distribution among U.S. singleton births: impact on rates of late preterm birth, 1992 to 2002. Semin Perinatol 2006, 30(1):8-15.
38. Hibbard J.U., Wilkins I., Sun L., et al. Respiratory morbidity in late preterm births. JAMA 2010, 304(4):419-425.
39. Yoder B.A., Gordon M.C., Barth W.H. Late-preterm birth: does the changing obstetric paradigm alter the epidemiology of respiratory complications?. Obstet Gynecol 2008, 111(4):814-822.
40. Hjalmarson O. Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 1981, 70(6):773-783.
41. Krantz M.E., Wennergren M., Bengtson L.G., et al. Epidemiological analysis of the increased risk of disturbed neonatal respiratory adaptation after caesarean section. Acta Paediatr Scand 1986, 75(5):832-839.
42. Wennergen M., Krantz M., Hjalmarson O., et al. Low Apgar score as a risk factor for respiratory disturbances in the newborn infant. J Perinat Med 1987, 15(2):153-160.
43. Dani C., Reali M.F., Bertini G., et al. Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology. Eur Respir J 1999, 14(1):155-159.
44. Rubaltelli F.F., Dani C., Reali M.F., et al. Acute neonatal respiratory distress in Italy: a one-year prospective study. Italian Group of Neonatal Pneumology. Acta Paediatr 1998, 87(12):1261-1268.
45. Clark R.H. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. J Perinatol 2005, 25(4):251-257.
46. Wang M.L., Dorer D.J., Fleming M.P., et al. Clinical outcomes of near-term infants. Pediatrics 2004, 114(2):372-376.
47. Dudell G.G., Jain L. Hypoxic respiratory failure in the late preterm infant. Clin Perinatol 2006, 33(4):803-830. [abstract: viii-ix].
48. Angus D.C., Linde-Zwirble W.T., Clermont G., et al. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med 2001, 164(7):1154-1160.
49. Jain L., Eaton D.C. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol 2006, 30(1):34-43.
50. Bland R.D. Lung epithelial ion transport and fluid movement during the perinatal period. Am J Physiol 1990, 259(2 Pt 1):L30-L37.
51. Jain L. Alveolar fluid clearance in developing lungs and its role in neonatal transition. Clin Perinatol 1999, 26(3):585-599.
52. Jain L., Chen X.J., Ramosevac S., et al. Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions. Am J Physiol Lung Cell Mol Physiol 2001, 280(4):L646-L658.
53. Venkatesh V.C., Katzberg H.D. Glucocorticoid regulation of epithelial sodium channel genes in human fetal lung. Am J Physiol 1997, 273(1 Pt 1):L227-L233.
54. Ventolini G., Neiger R., Mathews L., et al. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Am J Perinatol 2008, 25(2):79-83.
55. Escobar G.J., Greene J.D., Hulac P., et al. Rehospitalisation after birth hospitalisation: patterns among infants of all gestations. Arch Dis Child 2005, 90(2):125-131.
56. Vidaeff A.C., Ramin S.M., Gilstrap L.C., et al. Characterization of corticosteroid redosing in an in vitro cell line model. Am J Obstet Gynecol 2004, 191(4):1403-1408.
57. Vermillion S.T., Soper D.E., Newman R.B. Is betamethasone effective longer than 7 days after treatment?. Obstet Gynecol 2001, 97(4):491-493.
58. Sehdev H.M., Abbasi S., Robertson P., et al. The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants. Am J Obstet Gynecol 2004, 191(4):1409-1413.
59. Ring A.M., Garland J.S., Stafeil B.R., et al. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 2007, 196(5). 457,e1-6.
60. Antenatal corticosteroids revisited: repeat courses-National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol 2001, 98(1):144-150. National Institutes of Health Consensus Development Panel.
61. Wapner R.J., Sorokin Y., Thom E.A., et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006, 195(3):633-642.
62. Wapner R.J., Sorokin Y., Mele L., et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 2007, 357(12):1190-1198.
63. Sawady J., Mercer B.M., Wapner R.J., et al. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Beneficial Effects of Antenatal Repeated Steroids study: impact of repeated doses of antenatal corticosteroids on placental growth and histologic findings. Am J Obstet Gynecol 2007, 197(3). 281,e1-8.
64. Crowther C.A., Doyle L.W., Haslam R.R., et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med 2007, 357(12):1179-1189.
65. Murphy K.E., Hannah M.E., Willan A.R., et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008, 372(9656):2143-2151.
66. Modi N., Lewis H., Al-Naqeeb N., et al. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res 2001, 50(5):581-585.
67. McLaughlin K.J., Crowther C.A., Vigneswaran P., et al. Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks?. Aust N Z J Obstet Gynaecol 2002, 42(4):353-357.
68. Garite T.J., Kurtzman J., Maurel K., et al. Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol 2009, 200(3). 248,e1-9.
69. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2002. Natl Vital Stat Rep 2003, 52(10):1-113.
70. Choi S.J., Song S.E., Seo E.S., et al. The effect of single or multiple courses of antenatal corticosteroid therapy on neonatal respiratory distress syndrome in singleton versus twin pregnancies. Aust N Z J Obstet Gynaecol 2009, 49(2):173-179.
71. Blickstein I., Shinwell E.S., Lusky A., et al. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol 2005, 192(2):360-364.
72. Ballabh P., Lo E.S., Kumari J., et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 2002, 71(1):39-45.
73. Gyamfi C., Mele L., Wapner R.J., et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol 2010, 203(3). 219,e1-5.
74. Murphy D.J., Caukwell S., Joels L.A., et al. Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids. Am J Obstet Gynecol 2002, 187(2):483-488.
75. Hansen A.K., Wisborg K., Uldbjerg N., et al. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 2008, 336(7635):85-87.
76. Hansen A.K., Wisborg K., Uldbjerg N., et al. Elective caesarean section and respiratory morbidity in the term and near-term neonate. Acta Obstet Gynecol Scand 2007, 86(4):389-394.
77. Kolas T., Saugstad O.D., Daltveit A.K., et al. Planned cesarean versus planned vaginal delivery at term: comparison of newborn infant outcomes. Am J Obstet Gynecol 2006, 195(6):1538-1543.
78. Tita A.T., Landon M.B., Spong C.Y., et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009, 360(2):111-120.
79. Stutchfield P., Whitaker R., Russell I. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ 2005, 331(7518):662.
80. Sinclair J.C. Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion. Am J Obstet Gynecol 1995, 173(1):335-344.
81. Harding J.E., Pang J., Knight D.B., et al. Do antenatal corticosteroids help in the setting of preterm rupture of membranes?. Am J Obstet Gynecol 2001, 184(2):131-139.
82. Elimian A., Verma U., Beneck D., et al. Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet Gynecol 2000, 96(3):333-336.
83. Goldenberg R.L., Andrews W.W., Faye-Petersen O.M., et al. The Alabama preterm birth study: corticosteroids and neonatal outcomes in 23- to 32-week newborns with various markers of intrauterine infection. Am J Obstet Gynecol 2006, 195(4):1020-1024.
84. DiGiulio D.B., Romero R., Amogan H.P., et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One 2008, 3(8):e3056.
85. Knox C.L., Dando S.J., Nitsos I., et al. The severity of chorioamnionitis in pregnant sheep is associated with in vivo variation of the surface-exposed multiple-banded antigen/gene of Ureaplasma parvum. Biol Reprod 2010, 83(3):415-426.
86. Kallapur S.G., Kramer B.W., Moss T.J., et al. Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. Am J Physiol Lung Cell Mol Physiol 2003, 284(4):L633-L642.
87. Darmstadt G.L., Bhutta Z.A., Cousens S., et al. Evidence-based, cost-effective interventions: how many newborn babies can we save?. Lancet 2005, 365(9463):977-988.
88. Bassani D.G., Kumar R., Awasthi S. Causes of neonatal and child mortality in India: a nationally representative mortality survey. Lancet 2010, 376:1853-1860. Million Death Study Collaborators.
89. Bastek J.A., Sammel M.D., Rebele E.C., et al. The effects of a preterm labor episode prior to 34 weeks are evident in late preterm outcomes, despite the administration of betamethasone. Am J Obstet Gynecol 2010, 203(2). 140,e1-7.